Ian Campbell Obe

Ian Campbell OBE is a seasoned professional with extensive experience in leadership roles across various organizations in the life sciences and healthcare sectors. Currently serving as an Innovation Advisory Board Member at British Land and the Executive Director for Special Projects at KAUST, Ian also holds positions as a Trustee for Action Against AMD and a Non Executive Director at Cell and Gene Therapy Catapult. Additionally, Ian chairs the Board of Trustees at Advantage Schools and advises the Board at Cumulus Neuroscience. Previous roles include Chief Business Officer at LifeArc and Non Executive Chairman of MedCity. Ian's academic background includes a Ph.D. and a BSc in Biochemistry from the University of Glasgow.